News - imetelstat, Pharmaceutical

Filter

Current filters:

imetelstatPharmaceutical

Popular Filters

Geron slumps as imetelstat fails in Ph II breast cancer and NSCLC studies

11-09-2012

Shares of US drug developer Geron Corp (Nasdaq: GERN) plunged 50% to $1.44 in pre-market trading yesterday,…

Geron CorpimetelstatOncologyPharmaceuticalResearch

Back to top